Loading...
Publication
Quality of life of patients with prostate cancer
| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 482.76 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Enquadramento: O cancro da próstata é a segunda principal causa de
morte por cancro nos homens. O diagnóstico e tratamento podem provocar alterações
significativas na vida dos homens e, por consequência, modificar a sua qualidade de vida.
Objetivo: Avaliar as alterações na qualidade de vida do doente com patologia oncológica
da próstata, desde o momento do diagnóstico da doença até aos 6 meses de tratamento.
Metodologia: Foi desenvolvido um estudo descritivo, analítico e longitudinal com a
participação de doentes oncológicos, utilizando as escalas HRQoL, SF-12 e EQ-5D em
quatro momentos.
Resultados: Foram observadas alterações em dimensões da QVRS ao longo de quatro
momentos de avaliação, bem como ao nível da funcionalidade e dos sintomas.
Conclusão: Este estudo apresenta novas evidências sobre a QVRS dos doentes
portadores de patologia oncológica da próstata, nomeadamente em dimensões
relacionadas com funções emocionais e sociais, fadiga, náusea e vómito, insónia, sintomas
de obstipação e diarreia, atividade sexual, sintomas urinários, intestinais e relacionados
com o tratamento hormonal, desde o diagnóstico da doença aos 6 meses de tratamento.
Uma intervenção dos profissionais de saúde direcionada para os domínios mais afetados
pode proporcionar uma melhor qualidade de vida aos doentes.
Background: Prostate cancer is the second leading cause of death from cancer in men. Its diagnosis and treatment can significantly change their life and affect their quality of life. Objective: To assess the changes in the quality of life of patients with prostate cancer, from diagnosis to the 6th month of treatment. Methodology: A descriptive, analytical, and longitudinal study was conducted with prostate cancer patients, using HRQoL, SF-12, and EQ-5D scales in four moments. Results: Changes were found in HRQoL dimensions across the four moments, as well as in functioning and symptoms. Conclusion: is study provides new evidence on dimensions of HRQoL of patients with prostate cancer, namely emotional and social functions, fatigue, nausea and vomiting, insomnia, constipation and diarrhea symptoms, sexual activity, urinary, bowel symptoms, and hormonal treatment-related symptoms, from diagnosis to the 6th month of treatment. Health professionals should intervene in the most affected domains to improve the quality of life of prostate cancer patients.
Background: Prostate cancer is the second leading cause of death from cancer in men. Its diagnosis and treatment can significantly change their life and affect their quality of life. Objective: To assess the changes in the quality of life of patients with prostate cancer, from diagnosis to the 6th month of treatment. Methodology: A descriptive, analytical, and longitudinal study was conducted with prostate cancer patients, using HRQoL, SF-12, and EQ-5D scales in four moments. Results: Changes were found in HRQoL dimensions across the four moments, as well as in functioning and symptoms. Conclusion: is study provides new evidence on dimensions of HRQoL of patients with prostate cancer, namely emotional and social functions, fatigue, nausea and vomiting, insomnia, constipation and diarrhea symptoms, sexual activity, urinary, bowel symptoms, and hormonal treatment-related symptoms, from diagnosis to the 6th month of treatment. Health professionals should intervene in the most affected domains to improve the quality of life of prostate cancer patients.
Description
Keywords
Qualidade de vida Neoplasias da próstata
Citation
Revista de Enfermagem Referência, vol. V, núm. 1, 2020
Publisher
Escola Superior de Enfermagem de Coimbra